COL6A1-CLCN3 Fusion FISH Probe
The COL6A1-CLCN3 Fusion FISH Probe is used to confirm a fusion of the COL6A1 and CLCN3 genes. The fusion of the COL6A1 and CLCN3 genes has been associated with Colon Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| COL6A1-CLCN3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| COL6A1-CLCN3-20-AQAQ | 20 (40 μL) | 200 μL |
|
CLCN3 Gene Summary
This gene encodes a member of the voltage-gated chloride channel (ClC) family. The encoded protein is present in all cell types and localized in plasma membranes and in intracellular vesicles. It is a multi-pass membrane protein which contains a ClC domain and two additional C-terminal CBS (cystathionine beta-synthase) domains. The ClC domain catalyzes the selective flow of Cl- ions across cell membranes, and the CBS domain may have a regulatory function. This protein plays a role in both acidification and transmitter loading of GABAergic synaptic vesicles, and in smooth muscle cell activation and neointima formation. This protein is required for lysophosphatidic acid (LPA)-activated Cl- current activity and fibroblast-to-myofibroblast differentiation. The protein activity is regulated by Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) in glioma cells. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2011]
Gene Name: Chloride Voltage-gated Channel 3
Chromosome: CHR4: 170541671 -170644338
Locus: 4q33
COL6A1 Gene Summary
The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]
Gene Name: Collagen Type VI Alpha 1 Chain
Chromosome: CHR21: 47401662 -47424963
Locus: 21q22.3
Gene Diseases
The COL6A1 CLCN3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Colon Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|